January 30, 2018 / 12:06 PM / 19 days ago

BRIEF-Madrigal Announces Acceptance Of MGL-3196 Abstract For A Main Plenary Presentation

Jan 30 (Reuters) - Madrigal Pharmaceuticals Inc:

* MADRIGAL ANNOUNCES ACCEPTANCE OF MGL-3196 ABSTRACT FOR A MAIN PLENARY PRESENTATION AT THE INTERNATIONAL LIVER CONGRESS™ 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below